Tandem Diabetes Care (TNDM) Competitors $17.08 -0.16 (-0.93%) Closing price 07/2/2025 04:00 PM EasternExtended Trading$17.17 +0.09 (+0.53%) As of 07:06 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TNDM vs. IRTC, NARI, BLCO, TMDX, SLNO, INSP, NVST, PRCT, LIVN, and WRBYShould you be buying Tandem Diabetes Care stock or one of its competitors? The main competitors of Tandem Diabetes Care include iRhythm Technologies (IRTC), Inari Medical (NARI), Bausch + Lomb (BLCO), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Inspire Medical Systems (INSP), Envista (NVST), PROCEPT BioRobotics (PRCT), LivaNova (LIVN), and Warby Parker (WRBY). These companies are all part of the "medical equipment" industry. Tandem Diabetes Care vs. Its Competitors iRhythm Technologies Inari Medical Bausch + Lomb TransMedics Group Soleno Therapeutics Inspire Medical Systems Envista PROCEPT BioRobotics LivaNova Warby Parker Tandem Diabetes Care (NASDAQ:TNDM) and iRhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, media sentiment, institutional ownership, risk, earnings and dividends. Do analysts recommend TNDM or IRTC? Tandem Diabetes Care presently has a consensus target price of $33.43, suggesting a potential upside of 95.72%. iRhythm Technologies has a consensus target price of $138.60, suggesting a potential downside of 2.93%. Given Tandem Diabetes Care's higher possible upside, analysts plainly believe Tandem Diabetes Care is more favorable than iRhythm Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tandem Diabetes Care 0 Sell rating(s) 9 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.40iRhythm Technologies 0 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.90 Which has more volatility and risk, TNDM or IRTC? Tandem Diabetes Care has a beta of 1.48, indicating that its stock price is 48% more volatile than the S&P 500. Comparatively, iRhythm Technologies has a beta of 1.41, indicating that its stock price is 41% more volatile than the S&P 500. Is TNDM or IRTC more profitable? iRhythm Technologies has a net margin of -15.90% compared to Tandem Diabetes Care's net margin of -18.71%. Tandem Diabetes Care's return on equity of -57.33% beat iRhythm Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Tandem Diabetes Care-18.71% -57.33% -13.48% iRhythm Technologies -15.90%-101.04%-9.55% Does the media favor TNDM or IRTC? In the previous week, Tandem Diabetes Care had 1 more articles in the media than iRhythm Technologies. MarketBeat recorded 9 mentions for Tandem Diabetes Care and 8 mentions for iRhythm Technologies. Tandem Diabetes Care's average media sentiment score of 1.19 beat iRhythm Technologies' score of 1.11 indicating that Tandem Diabetes Care is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tandem Diabetes Care 3 Very Positive mention(s) 5 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive iRhythm Technologies 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings & valuation, TNDM or IRTC? Tandem Diabetes Care has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Tandem Diabetes Care, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTandem Diabetes Care$940.20M1.21-$96.03M-$2.78-6.14iRhythm Technologies$591.84M7.70-$113.29M-$3.14-45.47 SummaryTandem Diabetes Care beats iRhythm Technologies on 9 of the 14 factors compared between the two stocks. Get Tandem Diabetes Care News Delivered to You Automatically Sign up to receive the latest news and ratings for TNDM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TNDM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TNDM vs. The Competition Export to ExcelMetricTandem Diabetes CareMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.15B$6.89B$5.54B$8.87BDividend YieldN/A1.16%5.39%4.10%P/E Ratio-6.1426.5426.1619.90Price / Sales1.2195.96413.33113.66Price / CashN/A21.0136.1356.90Price / Book4.264.718.055.38Net Income-$96.03M$173.18M$3.15B$248.50M7 Day Performance-10.62%1.27%1.43%2.04%1 Month Performance-17.21%-0.32%3.62%4.84%1 Year Performance-57.11%25.79%34.92%20.23% Tandem Diabetes Care Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TNDMTandem Diabetes Care4.3049 of 5 stars$17.08-0.9%$33.43+95.7%-56.4%$1.15B$940.20M-6.142,650Positive NewsIRTCiRhythm Technologies1.2379 of 5 stars$153.96-0.5%$138.60-10.0%+44.8%$4.92B$618.59M-49.032,000Positive NewsInsider TradeNARIInari Medical0.4688 of 5 stars$79.97flat$69.22-13.4%N/A$4.68B$493.63M-59.24800BLCOBausch + Lomb3.3738 of 5 stars$13.03+5.1%$15.54+19.3%-6.2%$4.61B$4.79B-12.6513,500High Trading VolumeTMDXTransMedics Group1.6004 of 5 stars$134.01+1.9%$127.33-5.0%-14.3%$4.53B$441.54M98.54210Positive NewsSLNOSoleno Therapeutics4.2194 of 5 stars$83.78+0.6%$107.10+27.8%+117.0%$4.22BN/A-18.1330INSPInspire Medical Systems4.8514 of 5 stars$129.28-2.4%$211.91+63.9%-2.7%$3.81B$802.80M59.581,246Positive NewsNVSTEnvista3.5941 of 5 stars$19.58-0.5%$20.23+3.3%+23.5%$3.32B$2.51B-3.0012,300PRCTPROCEPT BioRobotics2.2019 of 5 stars$57.60+1.2%$90.00+56.3%-7.9%$3.19B$224.50M-33.88430LIVNLivaNova2.9208 of 5 stars$45.02-1.6%$59.29+31.7%-12.9%$2.45B$1.25B-11.012,900WRBYWarby Parker2.1214 of 5 stars$21.94+0.2%$22.88+4.3%+37.0%$2.29B$771.32M-182.833,780 Related Companies and Tools Related Companies IRTC Alternatives NARI Alternatives BLCO Alternatives TMDX Alternatives SLNO Alternatives INSP Alternatives NVST Alternatives PRCT Alternatives LIVN Alternatives WRBY Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TNDM) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredA grave, grave error.President Donald Trump made headlines last month with a staggering claim. He stated that since taking offic...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredMake 22x more from this summer’s Bitcoin boomBitcoin is on fire again. Wall Street’s piling in. ETFs are smashing volume records. And regular investors ...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tandem Diabetes Care, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tandem Diabetes Care With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
